DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES

DEFINITIVE CONTRACT won by INIMMUNE CORP · work in MISSOULA, MT
$7,776,786
RecipientINIMMUNE CORP UEI EF8AMXMGG8W5
Award ID75N93023C00042
Award amount$7,776,786
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — National Institutes of Health
NAICS541512 — COMPUTER SYSTEMS DESIGN SERVICES
PSCAN12
Set-asideUnrestricted
Start dateSep 30, 2023
End dateSep 29, 2028
Place of performanceMISSOULA, MT
Record updatedJul 14, 2026

View the official award record

More awards won by INIMMUNE CORP

PRODUCTION OF SYNTHETIC ADJUVANT SYSTEM (SAS): A SYNERGISTIC COMBINATION OF SYNTHETIC ADJUVANT COMPONENTS
Department of Health and Human Services · $1,992,471 · Jun 1, 2020
SBIR TOPIC 091 PHASE II: DEVELOPMENT OF A NEW TLR4 AGONIST FOR THE TREATMENT OF ALLERGIC RHINITIS
Department of Health and Human Services · $1,836,453 · Sep 1, 2021
ADJUVANT DISCOVERY FOR VACCINES AND FOR AUTOIMMUNE AND ALLERGIC DISEASES
Department of Health and Human Services · $598,808 · Sep 1, 2021

Our catalog shows awards with a value or ceiling of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. $0 today for 14 days (card required), then $49.99/month.

Search open bids